A Microfluidic Droplet Array System for Cell-Based Drug Combination Screening

Area of Science:

• Biotechnology
• Oncology
• Pharmacology

Background:

• Drug combination therapy is increasingly vital for treating complex diseases like cancer.
• Traditional screening methods face challenges in efficiency and drug consumption.

Purpose of the Study:

• To develop and demonstrate a microfluidic droplet system for efficient cell-based drug combination screening.
• To enable complex, long-term cell culture and drug testing with reduced reagent usage.

Main Methods:

• Utilized a microfluidic droplet system employing the Sequential Operation Droplet Array (SODA) technique.
• Integrated a 2D droplet array chip with an x-y-z translation stage and capillary-based liquid handling for automated operations.
• Performed complex multistep operations including cell culture, medium changes, drug dosing, and viability testing in parallel.

Main Results:

• Achieved substantial reduction in drug consumption per screening test (5 ng–5 μg), representing a 10- to 1000-fold decrease compared to traditional plate-based methods.
• Successfully executed complex, schedule-dependent drug screening and long-term cell culture within the microfluidic system.
• Demonstrated parallel processing capabilities for high-throughput drug combination screening.

Conclusions:

• The SODA microfluidic system offers a powerful and efficient platform for cell-based drug combination screening.
• This technology significantly reduces drug usage, making it a cost-effective and scalable approach for pharmaceutical research and development.